Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea (BABY HUG)

Pediatric Blood and Cancer

Volumn 54, Issue 2, 2010, Pages 265-268

  Miller, Scott T ^a   Wang, Winfred C ^b   Iyer, Rathi ^c   Rana, Sohail ^d   Lane, Peter ^e   Ware, Russell E ^b   Li, Daner ^f   Rees, Renée C ^f  

^a KINGS COUNTY HOSPITAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d HOWARD UNIVERSITY   (United States)

^e CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^f Clinical Trials & Surveys Corp   (United States)

Author keywords

Hyposthenuria; Isosthenuria; Nephropathy; Urine osmolality

Indexed keywords

CREATININE; HEMOGLOBIN F; HYDROXYUREA; NITROGEN; PENTETATE TECHNETIUM TC 99M; UREA;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; GROUPS BY AGE; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERUM OSMOLALITY; SICKLE CELL ANEMIA; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE OSMOLALITY;

ANEMIA, SICKLE CELL; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; INFANT; KIDNEY CONCENTRATING ABILITY; MALE; OSMOLAR CONCENTRATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 74849088905     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22189     Document Type: Article

References (18)

1. Josephs H. Clinical aspects of sickle cell anemia. Bull Johns Hopkins Hosp 1928;43:397-398.
2. Itano HA, Keitel HG, Thompson D. Hyposthenuria in sickle cell anemia: A reversible renal defect. J Clin Invest 1956;35:998-1007.
3. Kunz HW, Pratt EL, Mellin GW, et al. Impairment of urinary concentration in sickle cell anemia. Pediatrics 1954;13:352-356.
4. Statius van Eps LW, Schouten H, La Porte-Wijsman LW, et al. The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. Clin Chim Acta 1967; 17:449-461.
5. Noll JB, Newman AJ, Gross S. Enuresis and nocturia in sickle cell disease. J Pediatr 1967;70:965-967.
6. Radel EG, Kochen JA, Finberg L. Hyponatremia in sickle cell disease. A renal salt-losing state. J Pediatr 1976;88:800-805.
7. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-1322.
8. Ferster A, Tahriri P,Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001;97:3628-3632.
9. Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood 2005;106:2269-2275.
10. Wang WC, Helms RW, Lynn HS, et al. Effect of hydroxyurea on growth in children with sickle cell anemia: Results of the HUGKIDS Study. J Pediatr 2002;140:225-229.
11. Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer 2005;45:982-985.
12. Atiyeh BA, Dabbagh SS, Gruskin AB. Evaluation of renal function during childhood. Pediatr Rev 1996;17:175-180.
13. Statius van Eps LW, Pinedo-Veels C, de Vries GH, et al. Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet 1970;1:450-452.
14. Statius van Eps LW, Schouten H, Haar Romeny-Wachter CC, et al. The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 1970;27: 501-511.
15. Allon M, Lawson L, Eckman JR, et al. Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int 1988;34:500-506.
16. Hatch FE, Culbertson JW, Diggs LW. Nature of the renal concentrating defect in sickle cell disease. J Clin Invest 1967;46: 336-345.
17. Gupta AK, Kirchner KA, Nicholson R, et al. Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest 1991;88:1963-1968.
18. Iyer R, Baliga R, Nagel RL, et al. Maximum urine concentrating ability in children with Hb SC disease: Effects of hydroxyurea. Am J Hematol 2000;64:47-52.